Artiva Biotherapeutics (ARTV) Invested Capital (2023 - 2025)
Historic Invested Capital for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $129.2 million.
- Artiva Biotherapeutics' Invested Capital fell 3570.82% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.2 million, marking a year-over-year decrease of 3570.82%. This contributed to the annual value of $186.6 million for FY2024, which is 21519.98% up from last year.
- Artiva Biotherapeutics' Invested Capital amounted to $129.2 million in Q3 2025, which was down 3570.82% from $149.0 million recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Invested Capital ranged from a high of $201.0 million in Q3 2024 and a low of -$191.1 million during Q2 2024
- Its 3-year average for Invested Capital is -$880900.0, with a median of -$11.1 million in 2023.
- Per our database at Business Quant, Artiva Biotherapeutics' Invested Capital soared by 23271.09% in 2024 and then plummeted by 3570.82% in 2025.
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Invested Capital stood at -$162.0 million in 2023, then skyrocketed by 215.2% to $186.6 million in 2024, then plummeted by 30.76% to $129.2 million in 2025.
- Its last three reported values are $129.2 million in Q3 2025, $149.0 million for Q2 2025, and $168.8 million during Q1 2025.